51.1 F
New York
Monday, November 28, 2022

Date:

Share:

David Lim Joins the Team at Microvascular Therapeutics as Director of Finance

Related Articles

DonateStock Partners with GivingTuesday to Match $100,000 in Stock Gifts

Houston, TX, November 28, 2022 --(PR.com)-- DonateStock, a fintech philanthropy company, announced a $100,000 matching pool to boost stock gifts made on GivingTuesday, the most...
Tucson, AZ, November 25, 2022 –(PR.com)– Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all modalities.

“I have been working with the team at MVT since Q4 of 2021, and it has been my privilege to work alongside Dr. Unger, Dr. Meuillet, and the rest of the team. Dr. Unger, who is a pioneer in the ultrasound contrast agent, is a great entrepreneur, inventor, and innovator. Dr. Meuillet is an outstanding scientist and developer. With their leadership and MVT’s strong pipeline, MVT will tackle the unmet healthcare needs in cardiology, vascular thrombosis, oncology, and Alzheimer’s. We at MVT believe it is our mission to increase the time of life and increase the quality of life,”…

Read more…

Popular Articles